In the wake of heightened global trade tensions and significant market volatility, investors are increasingly cautious as they navigate an environment marked by steep declines in major indices. Amidst these challenges, identifying growth stocks with high insider ownership can offer a measure of confidence, as insider commitment often signals strong belief in a company's potential despite broader economic uncertainties.
Top 10 Growth Companies With High Insider Ownership Globally
| Name | Insider Ownership | Earnings Growth |
| Zhejiang Jolly PharmaceuticalLTD (SZSE:300181) | 23.3% | 26% |
| Seojin SystemLtd (KOSDAQ:A178320) | 32.1% | 39.3% |
| Pharma Mar (BME:PHM) | 11.8% | 40.8% |
| Vow (OB:VOW) | 13.1% | 111.2% |
| Laopu Gold (SEHK:6181) | 36.4% | 40% |
| Global Tax Free (KOSDAQ:A204620) | 20.8% | 35.1% |
| Nordic Halibut (OB:NOHAL) | 29.8% | 56.3% |
| CD Projekt (WSE:CDR) | 29.7% | 36.8% |
| Elliptic Laboratories (OB:ELABS) | 22.6% | 88.2% |
| Synspective (TSE:290A) | 13.2% | 44.5% |
We're going to check out a few of the best picks from our screener tool.
ABL Bio (KOSDAQ:A298380)
Simply Wall St Growth Rating: ★★★★★☆
Overview: ABL Bio Inc. is a biotech research company that develops therapeutic drugs for immuno-oncology and neurodegenerative diseases, with a market cap of ₩1.65 trillion.
Operations: The company's revenue primarily comes from its biotechnology startups segment, generating ₩33.40 billion.
Insider Ownership: 30.3%
ABL Bio is poised for significant growth, with revenue forecasted to increase by 22.4% annually, outpacing the Korean market's 7.1% growth rate. Despite current unprofitability, earnings are projected to grow at 45.27% per year and achieve profitability within three years, surpassing average market expectations. Recent strategic developments include a lucrative licensing agreement with GSK for its Grabody-B platform, potentially yielding up to £2.075 billion in milestone payments and royalties on future sales if successful products are commercialized.
- Click here and access our complete growth analysis report to understand the dynamics of ABL Bio.
- Our valuation report here indicates ABL Bio may be overvalued.
Beijing Dabeinong Technology GroupLtd (SZSE:002385)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Beijing Dabeinong Technology Group Co., Ltd. operates in the agricultural industry, focusing on animal feed and biotechnology products, with a market cap of CN¥17.38 billion.
Operations: Beijing Dabeinong Technology Group Co., Ltd. generates revenue primarily from its operations in the agricultural sector, specifically through animal feed and biotechnology products.
Insider Ownership: 26.6%
Beijing Dabeinong Technology Group is trading at a significant discount to its estimated fair value, with earnings projected to grow by 93.66% annually, surpassing the market average. Revenue growth is expected at 13.2% per year, slightly above the Chinese market's rate. However, low forecasted return on equity and inadequate interest coverage are concerns. Recent shareholder meetings focused on connected transactions for joint stock companies and project funding changes indicate ongoing strategic adjustments.
- Delve into the full analysis future growth report here for a deeper understanding of Beijing Dabeinong Technology GroupLtd.
- The analysis detailed in our Beijing Dabeinong Technology GroupLtd valuation report hints at an deflated share price compared to its estimated value.
Winall Hi-tech Seed (SZSE:300087)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Winall Hi-tech Seed Co., Ltd. focuses on the research, development, breeding, promotion, and service of various crop seeds both in China and internationally, with a market cap of approximately CN¥9.24 billion.
Operations: Revenue Segments (in millions of CN¥):
Insider Ownership: 14.2%
Winall Hi-tech Seed is poised for significant growth, with earnings forecasted to increase by 37.4% annually and revenue expected to grow at 23.3% per year, outpacing the Chinese market. However, its return on equity is projected to remain low at 15.9%, and profit margins have decreased from last year. The dividend yield of 0.96% is not well-supported by free cash flows, indicating potential sustainability issues despite high growth prospects in earnings and revenue.
- Take a closer look at Winall Hi-tech Seed's potential here in our earnings growth report.
- Our valuation report unveils the possibility Winall Hi-tech Seed's shares may be trading at a premium.
Where To Now?
- Gain an insight into the universe of 896 Fast Growing Global Companies With High Insider Ownership by clicking here.
- Looking For Alternative Opportunities? Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Mobile Infrastructure for Defense and Disaster
The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.
Get the investor briefing before the next round of contracts
Sponsored On Behalf of CiTechValuation is complex, but we're here to simplify it.
Discover if Winall Hi-tech Seed might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About SZSE:300087
Winall Hi-tech Seed
Researches, develops, breeds, promotes, and services various crop seeds in China.
Adequate balance sheet with moderate growth potential.
Market Insights
Weekly Picks
THE KINGDOM OF BROWN GOODS: WHY MGPI IS BEING CRUSHED BY INVENTORY & PRIMED FOR RESURRECTION

Why Vertical Aerospace (NYSE: EVTL) is Worth Possibly Over 13x its Current Price

The Quiet Giant That Became AI’s Power Grid
Recently Updated Narratives
Butler National (Buks) outperforms.

A tech powerhouse quietly powering the world’s AI infrastructure.

Keppel DC REIT (SGX: AJBU) is a resilient gem in the data center space.
Popular Narratives

MicroVision will explode future revenue by 380.37% with a vision towards success

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)
